Our latest News & Events
Registering gene therapy medicinal products
The regulatory requirements for the pharmaceutical development of gene therapy medicinal product are described in Annex I, part IV of Directive 2001/83/EC applied to advanced
How to manage a non-GMP raw material in your MA files?
French always do it different In many domains, French people like to stand out, either in a positive or negative way. In the Healthcare field,
How to proceed with non-pharmacopoeial excipients in the formulation of a medicinal product for human use?
French always do it different In many domains, French people like to stand out, either in a positive or negative way. In the Healthcare field,
Advertising for medicines: the keys to obtaining a visa in France
French always do it different In many domains, French people like to stand out, either in a positive or negative way. In the Healthcare field,
Do “over the counter” medicines exist in France?
French always do it different In many domains, French people like to stand out, either in a positive or negative way. In the Healthcare field,
LunchWork Atessia 11/05/22 “Nitrosamines: Final stretch to meet the deadlines”
On Wednesday 11 May 2022, our 4th Lunchwork of the year took place on the theme of nitrosamine impurities for which the regulatory deadlines are
LunchWork Atessia x LexCase 20/04/22 “Quality charter of professional practices for reimbursable products and services”
On Wednesday April 20, 2022, our 3rd Lunchwork of the year took place. On the occasion of this lunchtime event, accessible free of charge to
Atessia celebrates its 5th birthday!
Founded in 2017 by Géraldine Baudot-Visser, Atessia, Life Science Advisors is celebrating its 5th anniversary this year! 5 years during which our team of expert
Double certification: ISO 9001 & Qualiopi
ATESSIA is now certified by AFNOR according to two Quality standards: ISO 9001 for our expertise and consulting activity and Qualiopi for our in-company training offer.